EyePoint names Tarek Hassan chief strategic science officer
EYPT•EyePoint appoints Hassan to strategic science role
- EyePoint named Tarek S. Hassan as senior vice president, chief strategic science officer, reporting to CEO Jay S. Duker.
- The role targets strategy across the portfolio, including lead program DURAVYU, as Phase 3 wet AMD topline data nears.
- Hassan is a retina specialist with 35+ years’ experience, now a professor at Oakland University William Beaumont School of Medicine.
- He is also a senior partner at Associated Retinal Consultants, with experience across 180+ multicenter clinical trials.
